This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,231.97 firm fixed-price delivery order is for the supply of Humira (adalimumab) auto-injector pens, a specialty medication used to treat various autoimmune conditions.
The award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. The award has an ultimate completion date of December 20, 2024.
Generated 3/20/25, 9:49 AM